Skip to main content
SpringerLink
Log in

Ghrelin Reduces A-Type Potassium Currents in Dopaminergic Nigral Neurons via the PLC/PKCδ Pathway

  • Letter to the Editor
  • Published:
Neuroscience Bulletin Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402: 656–660.

    Article  CAS  Google Scholar 

  2. Mandal A, Prabhavalkar KS, Bhatt LK. Gastrointestinal hormones in regulation of memory. Peptides 2018, 102: 16–25.

    Article  CAS  Google Scholar 

  3. Jiao Q, Du X, Li Y, Gong B, Shi L, Tang T, et al. The neurological effects of ghrelin in brain diseases: beyond metabolic functions. Neurosci Biobehav Rev 2017, 73: 98–111.

    Article  CAS  Google Scholar 

  4. Andrews ZB, Erion D, Beiler R, Liu ZW, Abizaid A, Zigman J, et al. Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism. J Neurosci 2009, 29: 14057–14065.

    Article  CAS  Google Scholar 

  5. Shi L, Bian X, Qu Z, Ma Z, Zhou Y, Wang K, et al. Peptide hormone ghrelin enhances neuronal excitability by inhibition of Kv7/KCNQ channels. Nat Commun 2013, 4: 1435.

    Article  Google Scholar 

  6. Liu C, Xue Y, Liu MF, Wang Y, Liu ZR, Diao HL, et al. Orexins increase the firing activity of nigral dopaminergic neurons and participate in motor control in rats. J Neurochem 2018, 147: 380–394.

    Article  CAS  Google Scholar 

  7. Dragicevic E, Schiemann J, Liss B. Dopamine midbrain neurons in health and Parkinson’s disease: emerging roles of voltage-gated calcium channels and ATP-sensitive potassium channels. Neuroscience 2015, 284: 798–814.

    Article  CAS  Google Scholar 

  8. Chen X, Xue B, Wang J, Liu H, Shi L, Xie J. Potassium channels: a potential therapeutic target for Parkinson’s disease. Neurosci Bull 2018, 34: 341–348.

    Article  CAS  Google Scholar 

  9. Liss B, Franz O, Sewing S, Bruns R, Neuhoff H, Roeper J. Tuning pacemaker frequency of individual dopaminergic neurons by Kv4.3L and KChip3.1 transcription. EMBO J 2001, 20: 5715–5724.

  10. Haghdoost-Yazdi H, Piri H, Najafipour R, Faraji A, Fraidouni N, Dargahi T, et al. Blockade of fast A-type and TEA-sensitive potassium channels provide an antiparkinsonian effect in a 6-OHDA animal model. Neurosciences (Riyadh) 2017, 22: 44–50.

    Article  Google Scholar 

  11. Sun Q, Zang WJ, Chen C. Growth hormone secretagogues reduce transient outward K+ current via phospholipase C/protein kinase C signaling pathway in rat ventricular myocytes. Endocrinology 2010, 151: 1228–1235.

    Article  CAS  Google Scholar 

  12. Hoffman DA, Johnston D. Downregulation of transient K+ channels in dendrites of hippocampal CA1 pyramidal neurons by activation of PKA and PKC. J Neurosci 1998, 18: 3521–3528.

    Article  CAS  Google Scholar 

  13. Yang F, Feng L, Zheng F, Johnson SW, Du J, Shen L, et al. GDNF acutely modulates excitability and A-type K(+) channels in midbrain dopaminergic neurons. Nat Neurosci 2001, 4: 1071–1078.

    Article  CAS  Google Scholar 

  14. Yuan LL, Adams JP, Swank M, Sweatt JD, Johnston D. Protein kinase modulation of dendritic K+ channels in hippocampus involves a mitogen-activated protein kinase pathway. J Neurosci 2002, 22: 4860–4868.

    Article  CAS  Google Scholar 

  15. Delmas P, Brown DA. Pathways modulating neural KCNQ/M (Kv7) potassium channels. Nat Rev Neurosci 2005, 6: 850–862.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Natural Science Foundation of China (31671054, 31771124 and 81430024), the Postdoctoral Science Foundation of China (2017M610412 and 2018T110666), the Bureau of Science and Technology of Qingdao Municipality, China (17-1-1-44-jch), and the Taishan Scholars Construction Project of Shandong Province, China.

Author information

Authors and Affiliations

  1. Department of Physiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, School of Basic Medicine, Qingdao University, Qingdao, 266071, China

    Bao Xue, Chen Li, Xiaoli Chang, Hong Jiang, Limin Shi & Junxia Xie

  2. Institute of Brain Science and Disease, Qingdao University, Qingdao, 266071, China

    Bao Xue, Chen Li, Xiaoli Chang, Hong Jiang, Limin Shi & Junxia Xie

  3. Institute of Acupuncture, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China

    Xiaoli Chang

Authors
  1. Bao Xue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chen Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiaoli Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hong Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Limin Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Junxia Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Limin Shi or Junxia Xie.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 523 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xue, B., Li, C., Chang, X. et al. Ghrelin Reduces A-Type Potassium Currents in Dopaminergic Nigral Neurons via the PLC/PKCδ Pathway. Neurosci. Bull. 36, 947–950 (2020). https://doi.org/10.1007/s12264-020-00508-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12264-020-00508-4

Search

Navigation